{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:58:27Z","timestamp":1733896707812,"version":"3.30.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.humimm.2024.111091","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T13:36:09Z","timestamp":1726061769000},"page":"111091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina"],"prefix":"10.1016","volume":"85","author":[{"given":"Yantorno","family":"Silvina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curciarello","family":"Renata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizzo","family":"Gast\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferreyra","family":"Compagnucci Malena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tau","family":"Lorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delaplace","family":"Laura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Descalzi","family":"Valeria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gondolesi","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Docena","family":"Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumbo","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Virginia Gentilini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.humimm.2024.111091_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100776","article-title":"Vaccination in liver diseases and liver transplantation: Recommendations, implications and opportunities in the post-COVID era","volume":"5","author":"Ballester","year":"2023","journal-title":"JHEP Reports"},{"issue":"52","key":"10.1016\/j.humimm.2024.111091_b0010","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1016\/j.vaccine.2023.11.039","article-title":"Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients","volume":"41","author":"Ducasa","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.humimm.2024.111091_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2022.06.007","article-title":"Immunosuppressive Drugs in Liver Transplant: An Insight","volume":"12","author":"Panackel","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.humimm.2024.111091_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/lt.26273","article-title":"Antibody response to SARS-CoV-2 messenger RNA vaccines in liver transplant recipients","author":"Strauss","year":"2021","journal-title":"Liver Transpl."},{"issue":"2","key":"10.1016\/j.humimm.2024.111091_b0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10875-022-01382-7","article-title":"COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity","volume":"43","author":"Erra","year":"2023","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2024.111091_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1009161","article-title":"Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina","volume":"17","author":"Ojeda","year":"2021","journal-title":"PLoS Pathog."},{"issue":"38","key":"10.1016\/j.humimm.2024.111091_b0035","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1016\/j.vaccine.2022.08.027","article-title":"Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients","volume":"40","author":"Toapanta-Yanchapaxi","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2024.111091_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/lt.26273","article-title":"Antibody response to SARS-CoV-2 messenger RNA vaccines in liver transplant recipients","author":"Strauss","year":"2021","journal-title":"Liver Transpl."},{"issue":"2","key":"10.1016\/j.humimm.2024.111091_b0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.humimm.2024.111091_b0065","doi-asserted-by":"crossref","first-page":"Oct","DOI":"10.1016\/j.eclinm.2021.101126","article-title":"effectiveness of the First Component of Gam-COVID-Vac (sputnik v) on Reduction of SARS-CoV-2 Confirmed Infections, Hospitalisations and Mortality in Patients Aged 60\u201379: a Retrospective Cohort Study in Argentina","volume":"40","author":"Gonz\u00e1lez","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.humimm.2024.111091_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-022-01858-3","article-title":"Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis","volume":"19","author":"Mehrabi Nejad","year":"2022","journal-title":"Virol. J."},{"key":"10.1016\/j.humimm.2024.111091_b0050","doi-asserted-by":"crossref","unstructured":"V. G. Hall et al., \u201cHumoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients,\u201d American Journal of Transplantation, 21(12), 2021, 10.1111\/ajt.16766.","DOI":"10.1111\/ajt.16766"},{"issue":"7","key":"10.1016\/j.humimm.2024.111091_b0055","article-title":"Anti-sars-cov-2 immune responses in patients receiving an allogeneic stem cell or organ transplant","volume":"9","author":"Atanackovic","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.humimm.2024.111091_b0085","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1097\/TP.0000000000004256","article-title":"Factors Associated with COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis","volume":"106","author":"Li","year":"2022","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.humimm.2024.111091_b0090","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.kint.2021.04.005","article-title":"Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine","volume":"99","author":"Benotmane","year":"2021","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.humimm.2024.111091_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7774\/cevr.2023.12.1.13","article-title":"Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis","volume":"12","author":"Iryaningrum","year":"2023","journal-title":"Clinical and Experimental Vaccine Research"},{"issue":"12","key":"10.1016\/j.humimm.2024.111091_b0100","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1111\/ajt.17158","article-title":"mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to 2 mRNA vaccines in solid organ transplant recipients","volume":"22","author":"Bae","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2024.111091_b0105","article-title":"Garcia-valtanen, mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients","author":"Perkins","year":"2023","journal-title":"Affiliations"},{"key":"10.1016\/j.humimm.2024.111091_b0080","doi-asserted-by":"crossref","unstructured":"S. Y. Lim et al., \u201cAntibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients,\u201d Immune Network, vol. 22, no. 3, 2022, 10.4110\/in.2022.22.e24.","DOI":"10.4110\/in.2022.22.e24"},{"key":"10.1016\/j.humimm.2024.111091_b0110","doi-asserted-by":"crossref","unstructured":"F. Rosamilia et al., \u201cFlu and pneumococcal vaccine coverage in scleroderma patients still need to be prompted: A systematic review,\u201d Vaccines, vol. 9, no. 11. MDPI, Nov. 01, 2021. 10.3390\/vaccines9111330.","DOI":"10.3390\/vaccines9111330"},{"key":"10.1016\/j.humimm.2024.111091_b0115","doi-asserted-by":"crossref","unstructured":"G. Murdaca et al., \u201cVaccine-preventable infections in Systemic Lupus Erythematosus,\u201d Human Vaccines and Immunotherapeutics, vol. 12, no. 3. Taylor and Francis Inc., pp. 632\u2013643, Mar. 03, 2016. 10.1080\/21645515.2015.1107685.","DOI":"10.1080\/21645515.2015.1107685"},{"key":"10.1016\/j.humimm.2024.111091_b0120","doi-asserted-by":"crossref","unstructured":"G. Murdaca et al., \u201cSystemic sclerosis and vaccinations: A register-based cohort study about seasonal influenza and streptococcus pneumoniae vaccination rate and uptake from Liguria regional center, Northwest Italy,\u201d Vaccines (Basel), vol. 8, no. 2, Jun. 2020, 10.3390\/vaccines8020204.","DOI":"10.3390\/vaccines8020204"},{"key":"10.1016\/j.humimm.2024.111091_b0125","doi-asserted-by":"crossref","unstructured":"G. Murdaca et al., \u201cCurrent take on systemic sclerosis patients\u2019 vaccination recommendations,\u201d Vaccines, vol. 9, no. 12. MDPI, Dec. 01, 2021. 10.3390\/vaccines9121426.","DOI":"10.3390\/vaccines9121426"},{"key":"10.1016\/j.humimm.2024.111091_b0130","doi-asserted-by":"crossref","unstructured":"F. Ursini et al., \u201cInflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group,\u201d RMD Open, vol. 9, no. 2, Jun. 2023, 10.1136\/rmdopen-2023-003022.","DOI":"10.1136\/rmdopen-2023-003022"},{"key":"10.1016\/j.humimm.2024.111091_b0135","doi-asserted-by":"crossref","first-page":"Dec","DOI":"10.1016\/j.jtauto.2023.100212","volume":"7","author":"Ferri","year":"2023","journal-title":"J Transl Autoimmun"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924003513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924003513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T01:32:19Z","timestamp":1733880739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924003513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0198885924003513"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111091","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111091"}}